Researchers at the University of Illinois, US, has a developed new method that uses bacteria to produce 2-fucosyllactose (2FL), a sugar found abundantly in human milk.
This development could lead future research on the possibility of its addition to infant formula, say researchers.
2FL is a HMO (human milk oligosaccharide), which is found in abundance in breast milk and is believed to help strengthen the baby's immune system.
The new method uses a modified E. Coli strain to synthesize the 2FL.
Study researcher Yong-Su Jin said that as E. coli makes a starting material for 2FL as part of its normal metabolism, they decided to use the strain to produce the sugar.
"And we can use this technique to synthesize and study the hundreds of other HMOs in human milk too," added Miller
The researchers noted that by using the modified E. Coli strain, the bacterially synthesised 2FL can be produced rapidly and cheaply - about 1g of 2FL can be produced from 1l of E.coli broth.
Using the new technique, the researcher plan to initiate a study evaluating the role of 2FL in infant nutrition and also assess whether it can be added to infant formula. 2FL is not used in infant formula due to its high cost - about 1mg of 2FL costs about $100.
In addition to the ingredient's use in baby formula, the researchers suggest that it could be used to prevent Campylobacter contamination in chicken.
Lead researcher Michael Miller said that if poultry feed containing 2FL is fed to the chicken, the pathogens would bind to the oligosaccharide instead of the mucosal lining of the bird's intestine and can be destroyed even before the chicken reaches the retail outlets.
